Literature DB >> 22044315

Modeling inhalational tularemia: deliberate release and public health response.

Joseph R Egan1, Ian M Hall, Steve Leach.   

Abstract

Two epidemic modeling studies of inhalational tularemia were identified in the published literature, both demonstrating the high number of potential casualties that could result from a deliberate aerosolized release of the causative agent in an urban setting. However, neither study analyzed the natural history of inhalational tularemia nor modeled the relative merits of different mitigation strategies. We first analyzed publicly available human/primate experimental data and reports of naturally acquired inhalational tularemia cases to better understand the epidemiology of the disease. We then simulated an aerosolized release of the causative agent, using airborne dispersion modeling to demonstrate the potential number of casualties and the extent of their spatial distribution. Finally, we developed a public health intervention model that compares 2 mitigation strategies: targeting antibiotics at symptomatic individuals with or without mass distribution of antibiotics to potentially infected individuals. An antibiotic stockpile that is sufficient to capture all areas where symptomatic individuals were infected is likely to save more lives than treating symptomatic individuals alone, providing antibiotics can be distributed rapidly and their uptake is high. However, with smaller stockpiles, a strategy of treating symptomatic individuals alone is likely to save many more lives than additional mass distribution of antibiotics to potentially infected individuals. The spatial distribution of symptomatic individuals is unlikely to coincide exactly with the path of the dispersion cloud if such individuals are infected near their work locations but then seek treatment close to their homes. The optimal mitigation strategy will depend critically on the size of the release relative to the stockpile level and the effectiveness of treatment relative to the speed at which antibiotics can be distributed. © Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044315      PMCID: PMC3223019          DOI: 10.1089/bsp.2011.0004

Source DB:  PubMed          Journal:  Biosecur Bioterror        ISSN: 1538-7135


  48 in total

1.  Tularemia: a perusal of three hundred thirty-nine cases.

Authors:  F T DIENST
Journal:  J La State Med Soc       Date:  1963-04

2.  Aerogenic immunization of the monkey and guinea pig with live tularemia vaccine.

Authors:  H T EIGELSBACH; J J TULIS; E L OVERHOLT; W R GRIFFITH
Journal:  Proc Soc Exp Biol Med       Date:  1961-12

3.  An outbreak of primary pneumonic tularemia on Martha's Vineyard.

Authors:  K A Feldman; R E Enscore; S L Lathrop; B T Matyas; M McGuill; M E Schriefer; D Stiles-Enos; D T Dennis; L R Petersen; E B Hayes
Journal:  N Engl J Med       Date:  2001-11-29       Impact factor: 91.245

4.  Airborne tularemia in Sweden.

Authors:  S Dahlstrand; O Ringertz; B Zetterberg
Journal:  Scand J Infect Dis       Date:  1971

5.  Pneumonic tularemia on Martha's Vineyard.

Authors:  S M Teutsch; W J Martone; E W Brink; M E Potter; G Eliot; R Hoxsie; R B Craven; A F Kaufmann
Journal:  N Engl J Med       Date:  1979-10-11       Impact factor: 91.245

6.  Aerogenic immunization of man with live Tularemia vaccine.

Authors:  R B Hornick; H T Eigelsbach
Journal:  Bacteriol Rev       Date:  1966-09

Review 7.  Tularaemia.

Authors:  A Tärnvik; L Berglund
Journal:  Eur Respir J       Date:  2003-02       Impact factor: 16.671

8.  Adverse events associated with prolonged antibiotic use.

Authors:  Sharon B Meropol; K Arnold Chan; Zhen Chen; Jonathan A Finkelstein; Sean Hennessy; Ebbing Lautenbach; Richard Platt; Stephanie D Schech; Deborah Shatin; Joshua P Metlay
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-05       Impact factor: 2.890

Review 9.  Streptomycin and alternative agents for the treatment of tularemia: review of the literature.

Authors:  G Enderlin; L Morales; R F Jacobs; J T Cross
Journal:  Clin Infect Dis       Date:  1994-07       Impact factor: 9.079

Review 10.  The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?

Authors:  A F Kaufmann; M I Meltzer; G P Schmid
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

View more
  8 in total

Review 1.  A review of back-calculation techniques and their potential to inform mitigation strategies with application to non-transmissible acute infectious diseases.

Authors:  Joseph R Egan; Ian M Hall
Journal:  J R Soc Interface       Date:  2015-05-06       Impact factor: 4.118

2.  Generation and characterization of large-particle aerosols using a center flow tangential aerosol generator with a non-human-primate, head-only aerosol chamber.

Authors:  J Kyle Bohannon; Matthew G Lackemeyer; Jens H Kuhn; Jiro Wada; Laura Bollinger; Peter B Jahrling; Reed F Johnson
Journal:  Inhal Toxicol       Date:  2015-05-13       Impact factor: 2.724

3.  A dose and time response Markov model for the in-host dynamics of infection with intracellular bacteria following inhalation: with application to Francisella tularensis.

Authors:  R M Wood; J R Egan; I M Hall
Journal:  J R Soc Interface       Date:  2014-06-06       Impact factor: 4.118

4.  A combined enrichment and aptamer pulldown assay for Francisella tularensis detection in food and environmental matrices.

Authors:  Elise A Lamont; Ping Wang; Shinichiro Enomoto; Klaudyna Borewicz; Ahmed Abdallah; Richard E Isaacson; Srinand Sreevatsan
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

5.  A human time dose response model for Q fever.

Authors:  Charles W Heppell; Joseph R Egan; Ian Hall
Journal:  Epidemics       Date:  2017-06-15       Impact factor: 4.396

6.  The Cynomolgus Macaque Natural History Model of Pneumonic Tularemia for Predicting Clinical Efficacy Under the Animal Rule.

Authors:  Tina Guina; Lynda L Lanning; Kristian S Omland; Mark S Williams; Larry A Wolfraim; Stephen P Heyse; Christopher R Houchens; Patrick Sanz; Judith A Hewitt
Journal:  Front Cell Infect Microbiol       Date:  2018-04-04       Impact factor: 5.293

7.  A Methodology for Determining Which Diseases Warrant Care in a High-Level Containment Care Unit.

Authors:  Theodore J Cieslak; Jocelyn J Herstein; Mark G Kortepeter; Angela L Hewlett
Journal:  Viruses       Date:  2019-08-22       Impact factor: 5.048

Review 8.  Aerosol-Transmitted Infections-a New Consideration for Public Health and Infection Control Teams.

Authors:  Julian W Tang; Peter Wilson; Nandini Shetty; Catherine J Noakes
Journal:  Curr Treat Options Infect Dis       Date:  2015-07-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.